Atezolizumab,Bevacizumab
Roche
['hcc']
wow , so many practice-changing trials especially in #hpb will there be a role for neoadjuvant tx in high risk #hcc or perhaps perioperative 
Hedinger Chair of Surgical Oncology at OHSU Physician-in-Chief, Knight Cancer Institute 🇧🇷 🇺🇸 ⚽️ in #PNW 🏔️ 🌲 🌊 🎣 Tweets/Retweets/♥️ = own